Next Article in Journal
Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives
Previous Article in Journal
Isolated Effects of Plasma Freezing versus Thawing on Metabolite Stability
Previous Article in Special Issue
Molecular Network-Based Identification of Tramadol Metabolites in a Fatal Tramadol Poisoning
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Structural Diversity, LC-MS-MS Analysis and Potential Biological Activities of Brevibacillus laterosporus Extract

1
Department of Botany and Microbiology, Faculty of Science, Menoufia University, Menoufia 32511, Egypt
2
Department of Zoology, Faculty of Science, Menoufia University, Menoufia 32511, Egypt
3
Biology Department, Faculty of Science, Taibah University, Al Madinah 887, Saudi Arabia
4
Department of Fish Processing and Biotechnology, Faculty of Aquatic and Fisheries Sciences, Kafrelsheikh University, Kafrelsheikh 33516, Egypt
5
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
6
Department of Chemistry, Faculty of Science, Menoufia University, Menoufia 32511, Egypt
7
Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310058, China
8
Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, S-106 91 Stockholm, Sweden
9
International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China
10
Pharmacognosy Group, Department of Pharmaceutical Biosciences, Uppsala University, Biomedical Centre, SE 751-24 Uppsala, Sweden
11
International Joint Research Laboratory of Intelligent Agriculture and Agri-Products Processing, Jiangsu Education Department, Jiangsu University, Nanjing 210024, China
*
Authors to whom correspondence should be addressed.
Metabolites 2022, 12(11), 1102; https://doi.org/10.3390/metabo12111102
Submission received: 19 October 2022 / Revised: 6 November 2022 / Accepted: 9 November 2022 / Published: 11 November 2022

Abstract

:
Lake Mariout is Egypt’s degraded coastal marine habitat that encompasses a variety of wastes. The biodiversity and hard environmental conditions allow the co-existence of organisms with high resistance and rich metabolism, making them potential candidates for screening and isolating novel microbial strains. A bacterial isolate (BF202) cultured from the marine sediments of Alexandria’s Mariout Lake (Egypt) was tested for its antimicrobial and anticancer potential. The phylogenetic analysis of the isolated strain’s 16S rDNA and gyrB revealed that BF202 belongs to Brevibacillus laterosporus (B. laterosporus). Antibiosis of B. laterosporus was confirmed against microbial pathogens including Escherichia coli, Klebsiella pneumoniae, Salmonella typhi, and Staphylococcus aureus. The highest antibacterial activity was detected on glucose peptone medium after 18 h of incubation at 35 °C, and at pH of 7.0 in the presence of mannose and ammonium carbonate as carbon and nitrogen sources, respectively. The cytotoxicity of the methanolic extract against breast cancer (MCF-7) and normal Vero cell lines, using the MTT test, revealed IC50 values of 7.93 and 23.79 µg/mL, respectively. To identify apoptotic and necrotic cells, a flow cytometric analysis using annexin V-FITC/PI dual-labeling was utilized and recorded a higher number of necrotic cells compared to apoptotic ones. Similarly, the cell cycle S-phase arrest was reported. The LC-MS-MS investigation of B. laterosporus extract and the molecular networking database analysis demonstrated five strategic diketopiperazine compounds with antimicrobial and anticancer activities. Taken together, this research shows that the crude extract of B. laterosporus might be an effective agent against drug-resistant bacteria and malignant disorders due to its richness in diketopiperazines.

1. Introduction

Antibiotics resistance is one of the most serious challenges facing today’s healthcare system, posing a serious threat to public health [1,2] because of the spread, emergence, and persistence of multidrug-resistant (MDR) bacteria. Immediate and coordinated strategies are required to avoid the lethal threat posed by antibiotic-resistant microbes. One of the actions could be finding an alternative antimicrobial agent with a new mechanism of action. Antimicrobials are drugs that impede, alleviate, or treat illnesses caused by pathogens. These drugs can be grouped into various classes according to the target pathogens, such as antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are classified into two clusters: bactericidal (killing the bacteria) or bacteriostatic (reducing the bacteria development and proliferation) [3]. Accordingly, the underlying mechanisms of action can vary from interfering with cell wall formation, protein buildup, and nucleic acid generation to disrupting membrane functions and metabolic processes [4].
Equally as interesting, bacterial infection has been claimed to contribute cancer formation via two mechanisms: either the development of chronic inflammation—for instance, Helicobacter pylori infestation is claimed to be a pre-carcinogenic insult to the stomach, causing stomach cancer—or the production of mutagenic bacterial metabolites. [5,6]. Although in vivo research on the carcinogenesis of bacterial metabolites is conflicting, developing a medication that has antibacterial activity and potent anti-inflammatory and antioxidant properties can be a promising solution for prophylactic and curative protocols. Microbial peptides (MPs) can be potential candidates for this purpose, especially as they have anticancer effects, according to emerging data [7]. They have shown abilities to limit malignant cell proliferation as they electrostatically adhere to cancer cells’ negatively charged outer membranes, thus producing a cytotoxic effect via necrosis or apoptosis. Additionally, it was evidenced that they have a low likelihood of acquiring resistance or causing damage to healthy cells [1,8,9,10,11].
Brevibacillus sp. are among the species known for their ability to produce multiple short-sequence MPs along with antimicrobial agents such as glycopeptides, brevibacillin, and bacteriocin [12]. For example, brevilaterin B and other peptides extracted from Brevibacillus laterosporus S62-9 were recognized for their anticancer, antibacterial, and antifungal activities [13]. Similar effects were generated by Brevibacillus brevis EGS9 strain, as reported previously [14]. Moreover, bogorol, a peptide isolated from Brevibacillus laterosporus JX-5, exhibited potent antibacterial and anticancer activities [15]. Brevibacillus was described as a facultatively anaerobic, Gram-positive, and endospore-forming bacterium [16], and thus was further reclassified from Bacillus [17]. Brevibacillus can be found in various environments, including oceans, rivers, sediment, hot springs, soil, and compost [18].
Microorganisms, especially halophilic or halotolerant bacteria, from severe environments have recently received much attention for their ability to produce biosurfactants, enzymes, and antimicrobial agents as a tool to survive and defend their existence [19,20,21,22,23]. Some of these severe saline environments occur in Egypt, namely the lakes of Wadi Al-Natrun [24], the Solar Lake on the Sinai coast of the Gulf of Aqaba [25], and Mariout Lake in the city of Alexandria [26]. Mariout Lake is one of the Nile Delta’s most anthropogenically degraded and eutrophic wetlands due to outflows from the industrial and urban sectors [27]. The BF202 strain was distinguished from the early reported strains, i.e., JX-5 (GenBank: KF444391.1) and S62-9 (GenBank: EU709016.1), with the similarity presented as 99.22% and 99.39%, respectively. The 16S rRNA identities were applied and supported the notion that the alteration of the genetic structure could be ascribed to the effect of environmental factors [15,28].
We aimed to isolate halophilic and halotolerant bacteria from the hypersaline Mariout Lake in order to characterize the marine B. laterosporus BF202 and scrutinize their bioactivities. More attention was paid to the B. laterosporus BF202 isolated bioactive metabolites that could function as promising antibacterial and anticancer leads. To our knowledge, using LC-MS-MS analysis, identifying certain diketopiperazines, and investigating anticancer and antibacterial potentials in the crude extract of marine B. laterosporus of Egypt has not been realized before, and this is the first publication on this point in parallel to our continuous and ongoing interest to explore the chemical and biological features of natural organisms [29,30,31,32].

2. Materials and Methods

2.1. Isolation and Cultivation Conditions of Halotolerant Bacteria

Twenty soil sediment samples were collected from Mariout Lake (Alexandria, Egypt) at a depth of 30 cm and stored in a sterile polyethene packet at 4 °C. Five grams of each sediment sample were serially diluted with sterilized seawater. Each dilution was then spread onto a Petri dish containing tryptone soya agar (TSA) in seawater. The plates were kept for 48 h at 37 °C. The plates with 20–200 colonies were selected for further processing. The bacterial colonies were picked and streaked on TSA plates to obtain purified bacterial colonies.

2.2. Antibacterial Potencies against Pathogenic Bacteria

2.2.1. Paper Disc Assay

Using the paper disc assay, twenty isolates were screened for their antimicrobial potencies towards four microbial pathogens, namely E. coli ATCC 8739, S. typhi ATCC 14028 S. aureus ATCC 6598, and K. pneumoniae. A flask containing 50 mL of tryptone soya broth (pH 7.2) and about 1 mL (1.5 × 108 cfu/mL) of the purified bacteria was inoculated and incubated overnight at 100 rpm and 37 °C (Precise Shaking Incubator, WIS-RL010, Ulm, Germany). Following the incubation period, growing bacteria were collected at 3000 rpm for 30 min. A 0.45 µm bacterial filter was used to filter and sterilize the supernatant. The culture filtrate was used to saturate the filter paper disc (5 mm in diameter) to test its antagonistic activity. Then, the discs were placed gently on previously streaked plates by pathogenic bacteria. After incubation for 24 h at 37 °C, the inhibition zones’ diameters were taken. The most active isolates were chosen for further investigation.

2.2.2. Agar Well Diffusion Assay

At room temperature, 0.5 mL (1.5 × 108 cfu/mL) of fresh pathogenic bacteria spore suspensions was mixed with 9.5 mL of melting sterile Muller Hinton agar (45 °C), then poured onto sterile Petri dishes and allowed to solidify. A sterile cork borer with a 7 mm diameter was used to make wells in the inoculated agar plates. Each well was filled with 100 µL of the previously prepared sterile cell-free culture supernatant. The inhibition zones’ diameters were recorded after incubation for 24 h at 37 °C (Binder BD53, Tuttlingen, Germany) [33].

2.3. Molecular Identification of the Isolated Bacteria

The molecular identification of the isolated bacterium was performed through Macrogen, Korea. DNA extraction and purification were performed via InstaGene Matrix (BIO-RAD, cat. no. 732-6030), as described by the supplier’s protocol. Purified DNA was considered pure when the OD260/OD280 ratio was around 1.8 and the OD260/OD230 ratio was about 2.0. To sequence the 16S RNA encoding gene, the polymerase chain reaction (PCR) was performed using the Taq polymerase Dr. MAX DNA Polymerase (Doctor Protein, Korea, cat. no. DR00302) and the universal primers 27F/1492R through the DNA Engine Tetrad 2 Peltier Thermal cycler (Applied Biosystems, Foster City, CA, USA). The PCR product was purified through the Multiscreen Filter Plate (Millipore Corp., Darmstadt, Germany). Afterwards, the sequencing was performed using Sanger (dideoxy) technology via the sequencing kit BigDye (R) Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Vilnius, Lithuania) and using the universal primers 785F/907R. The sequencer ABI PRISM 3730XL Analyzer (96 capillary type) was used. After assembling the sequencing and removing the low-quality regions, the sequence was deposited in the nucleotide database of the National Center for Biotechnology Information [34]; the sequence identifier is OP03. However, it was not sufficient to discriminate Brevibacillus laterosporus from Brevibacillus halotolerans. The DNA gyrase subunit B was amplified through the thermal gradient PCR and using the forward primer 5′-CGAGCACTATCATATACCGAAGA-3′ and the reverse primer 5′-GGACTTTATCGCCCATTAAAACC-3′. The PCR thermal gradient program was a single cycle of 95 °C for 5 min and 30 s, followed by 35 cycles at 95 °C for 30 s, 48–68 °C for 30 s, 72 °C for 1 min, and an elongation step at 72 °C for 7 min. The gel electrophoresis was seen on a 1.5% agarose gel, 20 min running at 300 V, 200 A, and 2 µL of each PCR product was loaded into each well. Additionally, 2 µL of the GeneRuler DNA ladder Mix (#SM0331, Applied Biosystems, Vilnius, Lithuania) was loaded. Finally, the product of the annealing temperature of 60 °C was selected as the best and was sequenced with the same PCR primers. The obtained sequences were assembled into contig, and the low-quality regions were removed. The generated sequence was deposited into GenBank under the accession number OP105159.
To construct the phylogenetic trees, each sequence was used as a query in the BLASTN algorithm with a cutoff e-value of 1e−11 to retrieve the authentic homologous genes [35,36]. Retrieved sequences were aligned using MAFFT version 7 [37] (https://mafft.cbrc.jp/alignment/server/, accessed on 10 November 2022). A maximum likelihood phylogenetic tree was inferred assuming the K2P + G4 substitution model with 1000 bootstrap replicates for the 16S DNA homologous sequences and the SYM + R4 substitution model with 1000 bootstrap replicates for the DNA gyrase subunit B homologous sequences [38,39,40]. The downloaded phylogenetic trees were visualized and presented using the iTOL (Interactive Tree of Life) webserver [41].

2.4. Optimizing Culture Conditions of the B. laterosporus BF202 Antibacterial Activity

2.4.1. Different Types of Growth Media

The best medium for B. Laterosporus antibacterial activity was determined using various growth media. In Erlenmeyer flasks (250 mL) containing 48 mL of the studied growth medium, 2 mL of bacterium suspension (1.5 × 108 cfu/mL) was inoculated. The culture media used were glucose peptone medium [42], glycerol yeast extract [43], nutrient broth, and tryptic soy broth (dehydrated prepared media from HiMedia, India). The flasks were shaken on a rotary shaker (200 rpm/24 h/37 °C). All experiments were performed in triplicate. After incubation, each culture was centrifuged at 3000 rpm for 30 min (Centrifuge; Sigma 2-16P, Osterode, Germany), and the supernatants were used separately to evaluate the bacterium’s antimicrobial activity against S. aureus using the agar well diffusion technique.

2.4.2. Different Incubation Periods

In each 250 mL Erlenmeyer flask containing 48 mL of glucose peptone growth medium, a 2 mL inoculum of B. laterosporus (1.5108 cfu/mL) was cultured and incubated for different durations (18 to 72 h) under the same conditions as indicated previously. The agar well diffusion test was also used to assess the antibacterial activity of the cultures against S. aureus.

2.4.3. Different pH Values

The influence of various hydrogen ion concentrations on the antibacterial potency of the tested bacterium was investigated via the glucose peptone medium. Citrate–phosphate buffer pH (4.0 and 5.0), phosphate buffer pH (6.0 and 7.0), and Tris HCl buffer, pH 8.0, were used. The antibacterial activities were measured at pH 9.0 after incubation in a rotating shaker (37 °C/200 rpm/18 h).

2.4.4. Different Temperature Degrees

The organism was inoculated in glucose peptone medium (pH 7.0) to determine the optimal temperature for the tested bacterium’s antibacterial activity. It was then incubated at 200 rpm for 18 h under different temperatures, i.e., 15, 20, 25, 30, 35, and 40 °C. The antibacterial activities were determined in the manner described above.

2.4.5. Miscellaneous Carbon and Nitrogen Sources

To analyze the influence of various carbon and nitrogen sources on the antibacterial activity of B. laterosporus, the carbon source of the glucose peptone growth medium was replaced by an equal amount of either glycerol, sucrose, mannose, or maltose. In addition, one of the nitrogen-containing compounds (KNO3, NaNO3, NH4Cl, and (NH4)2CO3) was used to replace peptone in the peptone–glucose medium (using mannose instead of glucose). The equimolecular weight of each nitrogen compound was also considered. The antibacterial activities were determined as previously described.

2.5. Method for Preparing the Crude Extract

The isolated bacterium was grown on glucose peptone medium (GPM) in an incubator (100 rpm/35 °C /18 h). The supernatant was collected through centrifugation (6000 rpm/20 min), then filtered via a 0.45 μm bacterial filter. The filtrate was diluted by methanol (1:1), stirred (130 rpm/4 h), centrifuged (3000 rpm/10 min), and then evaporated through a vacuum rotary evaporator (Rotavapor, Heidolph, Schwabach, Germany). The crude extract was kept at −80 °C for future studies.

2.6. Characterization of Methanol Extract Using LC-MS/MS and GNPS

For LC-MS analysis, the powder extract was dissolved in 50% acetonitrile (ACN) and 0.1% formic acid (FA). The samples were injected with a syringe through a 0.3 µL/min PicoTip emitter connected to a QTof Micro (Waters, Milford, MS, USA) with the voltage set at 1.4 kV, positive ions and a linear gradient from 10% (v/v) H2O to 99% (v/v) ACN in 0.1% (v/v) FA at a flow rate of 0.3 µL/min for 75 min, followed by LC analysis/MS-MS dissolved by 0.1 mg/mL solvent LC-MS: 60% MeCN at 0.1 with a linear gradient of 10–60% (v/v) MeCN in 0.1% (v/v) FA at a flow rate of 0.3 mL/min for 75 min. The spray voltage was set to 4 kV and the capillary temperature was raised to 220 °C [44]. The raw MS file was analyzed using Global Natural Products (GNPS) Social Molecular Networking datasets [44,45]. GNPS aids in the identification and discovery of metabolites by comparing the matching between the fragmentation pattern from the raw mass spectrum and the GNPS library. To work with GNPS, we used other installed programs such as MSConvert, File Zilla, and Cytoscape version 3.5.1. The QTOF-(+)MS/MS data were acquired at a fixed collision energy of 1.4 kV, converted from Agilent MassHunter data files to mzXML file format using MSConvert, and then transferred to the GNPS server (https://gnps.ucsd.edu/, accessed on 5 December 2021) [46]. Molecular networking was accomplished using the GNPS data analysis workflow using the spectral clustering algorithm, a minimum of 6 matched peaks, and a cosine score of 0.7. Cytoscape version 3.5.1 was used to visualize the resulting spectral networks (https://cytoscape.org/, accessed on 10 December 2021) [47]. The confirmation of these metabolites was carried out using the Dictionary of Natural Products website and the literature search conducted using Sci-Finder, PubMed, and Google Scholar.

2.7. In Vitro Anticancer Study

2.7.1. Maintenance of Cell Lines

The Holding Company for Biological Products & Vaccines (VACSERA), Giza, Egypt, provided human breast adenocarcinoma (MCF-7) and normal African green monkey kidney (Vero) cell lines. A hemocytometer was used to determine the cell concentration per milliliter, which was then calculated using the following equation:
Cells/mL = 104 × (Average count per square) × (Dilution factor)
Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal calf serum, 100 U/mL penicillin, and 100 µg/mL streptomycin was used to maintain and culture the cell lines. Cells were cultured in T25 culture flasks at a density of 2 × 104 cells/cm2 in a humidified 5% CO2 atmosphere at 37 °C. Every 48 h, the medium was changed. An inverted microscope confirmed that the cells were 75% confluent. After trypsinization (0.025% trypsin and 0.02% EDTA), cells were harvested and washed twice with phosphate-buffered saline (PBS) [48]. All experiments were carried out in triplicate. All reagents and media were obtained from Lonza (Cairo, Egypt).

2.7.2. Cytotoxicity Assay

The cytotoxicity of crude bacterial extract was evaluated on MCF-7 cells and Vero normal green monkey kidney cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye (MTT). Briefly, the extract was tested 24 h after incubation with a series of extract dilutions. Cells were seeded at a density of 1 × 104 cells/well in a 96-well plate at 37 °C for 48 h in a 5% CO2 incubator and humidified atmosphere in a sterile environment until they reached 70% confluent monolayer. After 24 h of treatment, each well received 100 μL of MTT dye and was incubated for 4 h. Cells were washed with 100 μL PBS before being placed in a microtiter shaker with 100 μL of MTT de-staining solution (acidified isopropanol) for at least 10 min. To determine the number of viable cells, the optical density was measured using a microplate reader (RADIM SEAC Sirio S, Pomezia, Italy). The inhibition percentage was calculated as follows:
% Cell inhibition = (1−OD (absorbance) Test/OD Control) ×100
GraphPad Prism software (San Diego, CA, USA) was used to perform the inhibition curve and calculate the 50% maximal inhibitory concentration (IC50).

2.7.3. Characterization of Apoptosis Using Annexin V/Propidium Iodide (PI) Labeling

Apoptosis and necrosis were observed in the control MCF-7 cells versus the treated ones using flow cytometry via the Annexin V-FITC Kit (BD PharmingenTM, San Diego, CA, USA). Cells were collected, washed in PBS, then labeled with FITC-conjugated Annexin V and PI (Invitrogen, Carlsbad, CA, USA). The samples were analyzed with the BD AccuriTM C6 flow cytometer (San Jose, CA, USA).

2.7.4. Cell Cycle Analysis Using Flow Cytometer

A flow cytometer was used to investigate the effect of crude bacterial extract on the phases of the MCF-7 cell cycle. Cells rinsed with ice-cold PBS were fixed with ethanol, then stained in 1 mg/mL propidium iodide (PI) and 200 µg/mL RNase A-containing PBS for 15 min. The MODFIT DNA (Verity Software House, Topsham, ME, USA, version: 2.0) program determined the cell percentages in different phases. A flow cytometer (BD AccuriTM C6, San Jose, CA, USA) was employed for examining phase distribution.

3. Results

3.1. Isolation of Halotolerant Bacteria and the Estimation of Their Antibacterial Activities

A total of 20 bacterial samples were collected from various ecological saline habitats and isolated from soil sediment. One of the isolates demonstrated significant antibacterial activity against E. coli, K. pneumoniae, S. typhi, and S. aureus, as demonstrated by the filter paper disc assay. The inhibition zone diameters were sized 21, 20, 20, and 19 mm, respectively (Table 1). Moreover, the agar well diffusion method on Muller Hinton (MH) agar was utilized to confirm the results. The isolate’s filtrate inhibited the pathogenic bacteria, namely E. coli (23 mm), S. typhi (22 mm), K. pneumoniae (19 mm), and S. aureus (20 mm), at a rate close to the standard conventional antibiotic levofloxacin (50 mg/L), as shown in (Table 2).

3.2. Molecular Identification of the Bacterial Isolate

The 16S rRNA encoding gene V1-9 sequence was not enough to identify our isolate Brevibacillus laterosporus BF202 because it does not distinguish it well from the Brevibacillus halotolerans J5TS2 (Figure 1). March et al. [49] reported that 16S DNA is not satisfactory in separating B. laterosporus from other closely related species. Hereafter, the DNA gyrase subunit B (gyrB) gene was amplified through the gradient PCR (Figure 2), and its sequence was satisfactory to separate all the B. laterosporus strains into a distinct clade that is adequately separated from the other Brevibacillus species (Figure 3). The results also showed that the closest type of strain to our isolate is Brevibacillus laterosporus DSM 25, as indicated in Figure 3.

3.3. Optimization of the Culture Conditions of the B. laterosporus BF202

The antibacterial activity of B. laterosporus was studied under various culture media, mainly different incubation times, temperatures, pH levels, and carbon and nitrogen sources. Comparing different culture media, glucose peptone medium was found to be the most suitable growth medium for B. laterosporus (Figure 4A). As a result, the glucose peptone medium was used to optimize the other parameters. Then, the effect of different incubation times on the antibacterial activity of B. Laterosporus was scrutinized. The highest activity was observed after 18 h, while an additional 48 h incubation reduced the antimicrobial activity of B. Laterosporus filtrate by approximately 50% (Figure 4B).
The effect of different incubation temperatures on antibacterial activity was also studied. The results showed that raising the temperature to 35 °C increased antibacterial activity by more than 50% compared to 15 °C (Figure 4C), while raising the temperature to 40 °C reduced the inhibition zone by half. The same was noticed with the pH values, so pH of 7 was selected (Figure 4D).
In accordance with our measurements, mannose was the best carbon source, followed by glucose and sucrose. However, the lowest antibacterial activity was reported once glycerol was provided as a carbon source (Figure 4E). In regard to nitrogen sources, ammonium carbonate significantly enhanced the antimicrobial activity of the tested bacterial filtrate against S. aureus (Figure 4F).

3.4. LC-MS/MS Analysis of B. laterosporus Bioactive Extract

The GNPS molecular networking database was used to analyze the mass metabolites of B. laterosporus methanol extract. A total of 165 metabolites with their masses are shown as nodes in Figure 5. One metabolite is correspondent to each node. Several metabolites from similar classes are grouped together to form a single cluster along with their associated molecular weights. Names, parent masses, and fragments of identified metabolites are shown in Table 3. Five identified metabolites were classified as diketopiperazines and were named Cyclo (Leu-Pro), Cyclo (Val-Phe), Cyclo (Tyr-Pro), Cyclo (Ile-Tyr), Cyclo (Phe-Pro), and Tyr-Pro. Cyclo (Leu-Pro), Cyclo (Tyr-Pro), and Cyclo (Tyr-Ile), and were found in the same cluster as parent masses [M+H]+ (m/z; 211.257), [MH2O] + (m/z; 261.188), and [M+HH2O]+ (m/z; 277.29), respectively (Figure 6). Another Cyclo (Phe-Pro) node was noticed with the parent mass [M+HH2O]+ (m/z; 245.131) (Figure 7). In general, the identified metabolites have previously been reported to be promising antimicrobial and anti-tumor agents [52].

3.5. Cytotoxicity of the B. laterosporus Crude Extract

The MTT assay was used to determine the cytotoxicity of the bacterial crude extract against MCF-7 and Vero cells. The extract was cytotoxic to cancer cells (MCF-7) with a mean IC50 of 7.93 µg/mL. In contrast, cytotoxicity was minimum when tested on Vero normal cells, with a mean IC50 of 23.79 µg/mL (Figure 8).

3.6. Quantification of Apoptosis

Annexin V-FITC/PI dual labeling was used to detect apoptotic and necrotic cells (Figure 7). The extent of normal, total apoptotic, and necrotic cells was evaluated as the percentage of (Annexin V−/PI−), (Annexin V+/PI−) + (Annexin V+/PI+) and (Annexin V−/PI+) cells, respectively. In comparison to control records, higher concentrations lead to a significant increase in necrotic cells (27% and 97% for 4 and 8 µg/mL, respectively), whereas apoptotic cells did not change significantly among the extract incubation (Figure 9).

3.7. Cell Cycle Analysis Using Flow Cytometer

Staining with PI and flow cytometric analysis were used to assess the effect of the extract on the MCF-7 cell cycle distribution (Figure 10). After 72 h of treatment, the percentage of MCF-7 cells in the S-phase increased from 26.01 ± 0.44% (control group) to 26.89 ± 1.59 and 32.04 ± 0.83% corresponding to doses of 4 and 8 µg/mL, respectively. Only among the higher concentrations, the records significantly (p < 0.05) increased. However, the percentage of G2/M increased non-significantly, which is associated with a marked decrease in the G0/G1 phase, indicating that B. laterosporus extract inhibited the cell cycle in the S-phase. These observations are consistent with the findings of the necrosis observations, supporting the antiproliferative potential of the bacterial extract towards the MCF-7 cells.

4. Discussion

The capacity of marine microorganisms to create a diverse variety of bioactive metabolites demonstrates a key role in tackling several humanity-threatening challenges. Microbial metabolites may serve as antibacterial agents against a broad range of pathogenic microorganisms that have acquired resistance to current medications [56]. Furthermore, unlike conventional chemotherapeutics, unique natural chemicals may function as an effective antitumor medication that only kills cancer cells with minimal side effects on healthy ones [9]. For this study, different sediment samples were collected from various hypersaline environments in Egypt. One of the halotolerant isolates demonstrated potent antimicrobial activity against four pathogenic bacteria. The isolate was identified as B. laterosporus strain BF202. The first tool for the strain identification was to optimize the cultural conditions. Starting with the fermentation conditions, the maximum antibacterial activity of B. laterosporus filtrate was detected using a glucose peptone medium. The same method was applied by Usta et al. [57], who isolated B. laterosporus from various saline environments, including Paradip port in Odisha, India, and named B. laterosporus [58]. The bacterial filtrate was incubated for 18 h with continuous shaking, which is in contrast to [57], who recommended 28 h of incubation. On the other hand, mannose was the most used carbon source in our study owing to the superior antibacterial activity noticed in comparison to glucose and sucrose. In line with our observations, the results of Ak et al. [57] confirmed that mannose contributed to the maximum impact of B. laterosporus.
Ammonium carbonate outperformed other nitrogen sources in our study, as observed by the increase in B. laterosporus antibacterial activity against S. aureus. Ammonium is the primary nitrogen source that all microorganisms can directly use due to its easy absorption and metabolism [59]. Remarkable antibiotic activity of B. laterosporus ST-1 was also observed in cultures using glucose broth with yeast extract [59]. In another study, malt extract was recommended as the best nitrogen source, but the study doubted the role of yeast extract on culture [60]. Two other critical factors to be adjusted are the pH and temperature in order to balance the enzyme activity, oxidative-reductive reactions, and, most importantly, cellular membrane morphology. Among the pH values investigated, an initial pH of 7.0 resulted in the highest antibacterial activity of B. laterosporus, while a pH of 4.0 resulted in the lowest. This result was consistent with the outcomes of Usta et al. [57], who described the most significant antibacterial activity secondary to the application of pH 7.0. In parallel, 35 °C was the optimal temperature, in agreement with the previously reported data [57].
Five metabolites of B. laterosporus methanol extract were predicted by the GNPS molecular networking database in correlation to the proposed antimicrobial and antitumor activities, and classified as diketopiperazines. Diketopiperazines are the smallest known cyclic peptides, generally biosynthesized from amino acids. Moreover, diketopiperazines are produced by Gram-positive bacteria, fungi, and higher organisms, including mammals [61]. These groups of compounds have been evaluated for their antimicrobial, insecticidal, vasodilator, anti-tuberculosis, antioxidant, anti-viral, anti-prion, anti-hyperglycemic, and cytotoxic activities to demonstrate their potential applications in food, medicine, and agriculture [62]. Cyclo (Val-Phe), for instance, contributes to the antifungal properties of Lactobacillus plantarum [63], Cyclo (Ile-Tyr) of Pseudomonas rhizosphaerae exhibits antibacterial and antilarval potentials [64], and Cyclo (Phe-Pro) is claimed to induce apoptosis and thus to be effective as an antitumor molecule [65,66,67]. To the best of our knowledge, Cyclo (Val-Phe), Cyclo (Ile-Tyr), and Cyclo (Phe-Pro) are identified for the first time in this species. Quorum sensing (QS) facilitates communication processes among bacterial organisms, mediated by small, diffusible signals known as autoinducers and dependent on bacterial population density. Bacteria use QS to synchronize various functions, such as biofilm formation and pathogenicity. Quorum sensing is driven by autoinducer molecules, such as N-acyl-homoserine lactones produced by Gram-negative bacteria and oligopeptides-producing Gram-positive bacteria [68]. Diketopiperazines have interrupted the LuxR-mediated bacterial quorum-sensing systems, thus interfering with cell–cell communication [61]. As a result, diketopiperazines provide a new mechanism of action as anti-microbial agents manifested in the prevention of biofilm formation [61]. These results are in line with the findings published by [64,69,70,71], illustrating the antibacterial and antifungal properties of similar Cyclo peptides.
Interestingly, bacterial broth filtrate showed a potent cytotoxic effect on cancer cells (MCF-7) (IC50 = 7.93 µg/mL) and was harmless to normal cells. It is widely documented that apoptosis is a crucial factor in tumor regression, and ablation enhances tumor development [72].
In this vein, diketopiperazine compounds were proven effective as antioxidant and cytotoxic entities, supporting the antiproliferative potential against MCF-7 cells in this study [62]. The possible mechanisms of action have been discussed previously [73] and explained by foraging the intracellular ROS, such as superoxide, hydroxyl radicals, and hydrogen peroxide, besides diminishing the cytotoxicity and genotoxicity of the normal cells. The selective action was also reported by [73], documenting the antitumor activity of diketopiperazine Cyclo(L-Pro-D-Arg) against HeLa cells with an IC50 of 50 μg/mL while displaying no cytotoxicity against normal monkey kidney cells (Vero) using a concentration of up to 100 μg/mL. All in all, the data indicate that diketopiperazines extracted from B. laterosporus have a potent impact against drug-resistant germs and cancerous cells.

5. Conclusions

The discovery of new bioactive compounds is a cornerstone for developing new pharmaceuticals. This study succeeds in determining the antibacterial and anticancer characteristics of the B. laterosporus broth filtrate. The ideal culture conditions for achieving the best antibiosis potential were first characterized prior to testing the metabolites on the MCF-7 cell lines. The B. laterosporus metabolites, namely diketopiperazines, were identified employing the LC-MS-MS data, and the antimicrobial and anticancer biological properties were confirmed both in vitro and by employing the molecular networking database. The results raise awareness of the importance of the evolved natural products including the halophilic dwelling bacteria of the Egyptian hypersaline habitats and thus invite scrutiny of their bioactivities. The findings highlight new approaches to investigate and explore uncommon natural resources with the hope of introducing new entities to the medical and pharmaceutical fields.

Author Contributions

Conceptualization, S.M.E.-S., H.R.E.-S., I.M.E.-G. and M.Z.; methodology, M.Z., S.M.E.-S., H.R.E.-S., B.A. and I.M.E.-G.; writing—original draft preparation, N.E., S.M.E.-S., B.A., H.R.E.-S. and I.M.E.-G.; writing—review and editing, A.A.T., M.F.A., S.M.A., H.M.S.I., Q.S., S.A.M.K., N.E. and M.Z.; Supervision, S.M.E.-S. and H.R.E.-S.; Funding, M.F.A. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the researchers supporting project under group number (RSP-2021/122), King Saud University, Riyadh, Saudi Arabia.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the generous support from the researchers supporting project under group number (RSP-2021/122), King Saud University, Riyadh, Saudi Arabia. H.R. thanks Jiangsu University for adjunct professor fellowship. Q. Shou and H. El-Seedi highly appreciated and thanks: Plan of High end Foreign Experts of the Ministry of Science and Technology (G2022016009L).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Deslouches, B.; Di, Y.P. Antimicrobial Peptides with Selective Antitumor Mechanisms: Prospect for Anticancer Applications. Oncotarget 2017, 8, 46635. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kamenshchikova, A.; Wolffs, P.F.G.; Hoebe, C.; Horstman, K. Anthropocentric Framings of One Health: An Analysis of International Antimicrobial Resistance Policy Documents. Crit. Public Health 2021, 31, 306–315. [Google Scholar] [CrossRef] [Green Version]
  3. Eric, N.; Janet, L.; Steven, K.G. Inflammation, Immune Activation, and Cardiovascular Disease in HIV. AIDS 2016, 30, 1495. [Google Scholar]
  4. Hale, J.D.F.; Hancock, R.E.W. Alternative Mechanisms of Action of Cationic Antimicrobial Peptides on Bacteria. Expert Rev. Anti Infect. Ther. 2007, 5, 951–959. [Google Scholar] [CrossRef] [PubMed]
  5. Vogelmann, R.; Amieva, M.R. The Role of Bacterial Pathogens in Cancer. Curr. Opin. Microbiol. 2007, 10, 76–81. [Google Scholar] [CrossRef] [PubMed]
  6. Alipour, M. Molecular Mechanism of Helicobacter Pylori-Induced Gastric Cancer. J. Gastrointest. Cancer 2021, 52, 23–30. [Google Scholar] [CrossRef] [PubMed]
  7. Deslouches, B.; Steckbeck, J.D.; Craigo, J.K.; Doi, Y.; Burns, J.L.; Montelaro, R.C. Engineered Cationic Antimicrobial Peptides to Overcome Multidrug Resistance by ESKAPE Pathogens. Antimicrob. Agents Chemother. 2015, 59, 1329–1333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Siegal, R.; Miller, K.D.; Jemal, A. Cancer Statistics, 2012. CA Cancer J. Clin. 2014, 64, 9–29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Ting, C.-H.; Huang, H.-N.; Huang, T.-C.; Wu, C.-J.; Chen, J.-Y. The Mechanisms by Which Pardaxin, a Natural Cationic Antimicrobial Peptide, Targets the Endoplasmic Reticulum and Induces c-FOS. Biomaterials 2014, 35, 3627–3640. [Google Scholar] [CrossRef]
  10. Tornesello, A.L.; Borrelli, A.; Buonaguro, L.; Buonaguro, F.M.; Tornesello, M.L. Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities. Molecules 2020, 25, 2850. [Google Scholar] [CrossRef]
  11. Figueiredo, C.R.; Matsuo, A.L.; Massaoka, M.H.; Polonelli, L.; Travassos, L.R. Anti-Tumor Activities of Peptides Corresponding to Conserved Complementary Determining Regions from Different Immunoglobulins. Peptides 2014, 59, 14–19. [Google Scholar] [CrossRef] [PubMed]
  12. Krachkovskii, S.A.; Sobol, A.G.; Ovchinnikova, T.V.; Tagaev, A.A.; Yakimenko, Z.A.; Azizbekyan, R.R.; Kuznetsova, N.I.; Shamshina, T.N.; Arseniev, A.S. Isolation, Biological Properties, and Spatial Structure of Antibiotic Loloatin A. Russ. J. Bioorganic Chem. 2002, 28, 269–273. [Google Scholar] [CrossRef] [PubMed]
  13. Chen, Z.; Wang, L.; Liu, Y.; Han, P.; Hong, D.; Li, S.; Ma, A.; Jia, Y. Brevilaterin B from Brevibacillus Laterosporus Has Selective Antitumor Activity and Induces Apoptosis in Epidermal Cancer. World J. Microbiol. Biotechnol. 2022, 38, 201. [Google Scholar] [CrossRef] [PubMed]
  14. Arumugam, T.; Senthil Kumar, P.; Hemavathy, R.V.; Swetha, V.; Karishma Sri, R. Isolation, Structure Elucidation and Anticancer Activity from Brevibacillus Brevis EGS 9 That Combats Multi Drug Resistant Actinobacteria. Microb. Pathog. 2018, 115, 146–153. [Google Scholar] [CrossRef] [PubMed]
  15. Jiang, H.; Ji, C.; Sui, J.; Sa, R.; Wang, X.; Liu, X.; Guo, T.L. Antibacterial and Antitumor Activity of Bogorol B-JX Isolated from Brevibacillus Laterosporus JX-5. World J. Microbiol. Biotechnol. 2017, 33, 177. [Google Scholar] [CrossRef]
  16. Laubach, C.A. Studies On Aerobic Spore-Bearing Non-Pathogenic Bacteria Part II Spore-Bearing Bacteria In Dust. J. Bacteriol. 1916, 1, 493–533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Shida, O.; Takagi, H.; Kadowaki, K.; Komagata, K. Proposal for Two New Genera, Brevibacillus Gen. Nov. and Aneurinibacillus Gen. Nov. Int. J. Syst. Bacteriol. 1996, 46, 939–946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Singh, P.K.; Sharma, V.; Patil, P.B.; Korpole, S. Identification, Purification and Characterization of Laterosporulin, a Novel Bacteriocin Produced by Brevibacillus Sp. Strain GI-9. PLoS ONE 2012, 7, e31498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Manikandan, P.; Senthilkumar, P.K. On Overview of Saltpan Halophilic Bacterium. Antimicrob. Agents 2017, 3, 1–5. [Google Scholar]
  20. Vasavada, S.H.; Thumar, J.T.; Singh, S.P. Secretion of a Potent Antibiotic by Salt-Tolerant and Alkaliphilic Actinomycete Streptomyces Sannanensis Strain RJT-1. Curr. Sci. 2006, 91, 1393–1397. [Google Scholar]
  21. Chamekh, R.; Deniel, F.; Donot, C.; Jany, J.-L.; Nodet, P.; Belabid, L. Isolation, Identification and Enzymatic Activity of Halotolerant and Halophilic Fungi from the Great Sebkha of Oran in Northwestern of Algeria. Mycobiology 2019, 47, 230–241. [Google Scholar] [CrossRef] [PubMed]
  22. Fariq, A.; Yasmin, A.; Jamil, M. Production, Characterization and Antimicrobial Activities of Bio-Pigments by Aquisalibacillus Elongatus MB592, Salinicoccus Sesuvii MB597, and Halomonas Aquamarina MB598 Isolated from Khewra Salt Range, Pakistan. Extremophiles 2019, 23, 435–449. [Google Scholar] [CrossRef]
  23. Mainka, T.; Weirathmüller, D.; Herwig, C.; Pflügl, S. Potential Applications of Halophilic Microorganisms for Biological Treatment of Industrial Process Brines Contaminated with Aromatics. J. Ind. Microbiol. Biotechnol. 2021, 48, kuab015. [Google Scholar] [CrossRef]
  24. Mesbah, N.M.; Hedrick, D.B.; Peacock, A.D.; Rohde, M.; Wiegel, J. Natranaerobius Thermophilus Gen. Nov., Sp. Nov., a Halophilic, Alkalithermophilic Bacterium from Soda Lakes of the Wadi An Natrun, Egypt, and Proposal of Natranaerobiaceae Fam. Nov. and Natranaerobiales Ord. Nov. Int. J. Syst. Evol. Microbiol. 2007, 57, 2507–2512. [Google Scholar] [CrossRef] [PubMed]
  25. Cohen, Y.; Krumbein, W.E.; Goldberg, M.; Shilo, M. Solar Lake (Sinai). 1. Physical and Chemical Limnology 1. Limnol. Oceanogr. 1977, 22, 597–608. [Google Scholar] [CrossRef]
  26. Asker, D.; Ohta, Y. Haloferax Alexandrinus Sp. Nov., an Extremely Halophilic Canthaxanthin-Producing Archaeon from a Solar Saltern in Alexandria (Egypt). Int. J. Syst. Evol. Microbiol. 2002, 52, 729–738. [Google Scholar] [PubMed] [Green Version]
  27. Eltarahony, M.; Ibrahim, A.; El-shall, H.; Ibrahim, E.; Althobaiti, F.; Fayad, E. Antibacterial, Antifungal and Antibiofilm Activities of Silver Nanoparticles Supported by Crude Bioactive Metabolites of Bionanofactories Isolated from Lake Mariout. Molecules 2021, 26, 3027. [Google Scholar] [CrossRef] [PubMed]
  28. Chen, Z.; Wang, L.; Hong, D.; Liu, Y.; Han, P.; Li, S.; Jia, Y. Broad-spectrum Cytotoxicity to Cancer Cells of Brevilaterin C from Brevibacillus laterosporus and Its Specific Mechanism on Human Epidermal Cancer Cells. J. Cell. Biochem. 2022, 123, 1237–1246. [Google Scholar] [CrossRef] [PubMed]
  29. El-Garawani, I.M.; El-Sabbagh, S.M.; Abbas, N.H.; Ahmed, H.S.; Eissa, O.A.; Abo-Atya, D.M.; Khalifa, S.A.M.; El-Seedi, H.R. A Newly Isolated Strain of Halomonas Sp.(HA1) Exerts Anticancer Potential via Induction of Apoptosis and G2/M Arrest in Hepatocellular Carcinoma (HepG2) Cell Line. Sci. Rep. 2020, 10, 1–15. [Google Scholar] [CrossRef]
  30. Khalifa, S.A.M.; Elias, N.; Farag, M.A.; Chen, L.; Saeed, A.; Hegazy, M.-E.F.; Moustafa, M.S.; Abd El-Wahed, A.; Al-Mousawi, S.M.; Musharraf, S.G.; et al. Marine Natural Products: A Source of Novel Anticancer Drugs. Mar. Drugs 2019, 17, 491. [Google Scholar] [CrossRef] [Green Version]
  31. Khalifa, S.A.M.; Shedid, E.S.; Saied, E.M.; Jassbi, A.R.; Jamebozorgi, F.H.; Rateb, M.E.; Du, M.; Abdel-Daim, M.M.; Kai, G.-Y.; Al-Hammady, M.A.M.; et al. Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications. Mar. Drugs 2021, 19, 241. [Google Scholar] [CrossRef] [PubMed]
  32. Yosri, N.; Khalifa, S.A.M.; Guo, Z.; Xu, B.; Zou, X.; El-Seedi, H.R. Marine Organisms: Pioneer Natural Sources of Polysaccharides/Proteins for Green Synthesis of Nanoparticles and Their Potential Applications. Int. J. Biol. Macromol. 2021, 193, 1767–1798. [Google Scholar] [CrossRef] [PubMed]
  33. Holmalahti, J.; von Wright, A.; Raatikainen, O. Variations in the Spectra of Biological Activities of Actinomycetes Isolated from Different Soils. Lett. Appl. Microbiol. 1994, 18, 144–146. [Google Scholar] [CrossRef]
  34. NCBI Resource Coordinators. Database Resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2016, 44, D7–D19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Zayed, M.; Badawi, M.A. In-Silico Evaluation of a New Gene from Wheat Reveals the Divergent Evolution of the CAP160 Homologous Genes Into Monocots. J. Mol. Evol. 2020, 88, 151–163. [Google Scholar] [CrossRef] [PubMed]
  36. Pearson, W.R. An Introduction to Sequence Similarity (“Homology”) Searching. Curr. Protoc. Bioinforma. 2013, 42, 3.1.1–3.1.8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Katoh, K.; Rozewicki, J.; Yamada, K.D. MAFFT Online Service: Multiple Sequence Alignment, Interactive Sequence Choice and Visualization. Brief. Bioinform. 2019, 20, 1160–1166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Nguyen, L.-T.; Schmidt, H.A.; von Haeseler, A.; Minh, B.Q. IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies. Mol. Biol. Evol. 2015, 32, 268–274. [Google Scholar] [CrossRef] [PubMed]
  39. Trifinopoulos, J.; Nguyen, L.-T.; von Haeseler, A.; Minh, B.Q. W-IQ-TREE: A Fast Online Phylogenetic Tool for Maximum Likelihood Analysis. Nucleic Acids Res. 2016, 44, W232–W235. [Google Scholar] [CrossRef] [Green Version]
  40. Minh, B.Q.; Nguyen, M.A.T.; von Haeseler, A. Ultrafast Approximation for Phylogenetic Bootstrap. Mol. Biol. Evol. 2013, 30, 1188–1195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Letunic, I.; Bork, P. Interactive Tree of Life (ITOL) v3: An Online Tool for the Display and Annotation of Phylogenetic and Other Trees. Nucleic Acids Res. 2016, 44, W242–W245. [Google Scholar] [CrossRef] [PubMed]
  42. Atlas, R.M. Handbook of Microbiological Media; CRC Press: Boca Raton, FL, USA, 2004; ISBN 0429129033. [Google Scholar]
  43. Rogosa, M.; Mitchell, J.A.; Wiseman, R.F. A Selective Medium for the Isolation and Enumeration of Oral and Fecal Lactobacilli. J. Bacteriol. 1951, 62, 132–133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. El-Garawani, I.M.; Hassab El-Nabi, S.; El Kattan, A.; Sallam, A.; Elballat, S.; Abou-Ghanima, S.; El Azab, I.H.; El-Seedi, H.R.; Khalifa, S.A.M.; El-Shamy, S. The Ameliorative Role of Acacia Senegal Gum against the Oxidative Stress and Genotoxicity Induced by the Radiographic Contrast Medium (Ioxitalamate) in Albino Rats. Antioxidants 2021, 10, 221. [Google Scholar] [CrossRef] [PubMed]
  45. El-Din, M.I.G.; Fahmy, N.M.; Wu, F.; Salem, M.M.; Khattab, O.M.; El-Seedi, H.R.; Korinek, M.; Hwang, T.-L.; Osman, A.K.; El-Shazly, M. Comparative LC–LTQ–MS–MS Analysis of the Leaf Extracts of Lantana Camara and Lantana Montevidensis Growing in Egypt with Insights into Their Antioxidant, Anti-Inflammatory, and Cytotoxic Activities. Plants 2022, 11, 1699. [Google Scholar] [CrossRef]
  46. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T. Sharing and Community Curation of Mass Spectrometry Data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef] [Green Version]
  47. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 2498–2504. [Google Scholar] [CrossRef] [PubMed]
  48. El-Garawani, I.; El-Seedi, H.; Khalifa, S.; El Azab, I.H.; Abouhendia, M.; Mahmoud, S. Enhanced Antioxidant and Cytotoxic Potentials of Lipopolysaccharides-Injected Musca Domestica Larvae. Pharmaceutics 2020, 12, 1111. [Google Scholar] [CrossRef]
  49. Marche, M.G.; Mura, M.E.; Ruiu, L. Rapid Polymerase Chain Reaction Assays for Brevibacillus Laterosporus Detection. J. Basic Microbiol. 2019, 59, 853–857. [Google Scholar] [CrossRef] [PubMed]
  50. De Mendiburu, F.; Simon, R. Agricolae-Ten Years of an Open Source Statistical Tool for Experiments in Breeding, Agriculture and Biology. PeerJ Prepr. 2015, 3, e1404v1. [Google Scholar] [CrossRef]
  51. R Development Core Team R. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2013. [Google Scholar]
  52. Deepak, P.; Kim, W.; Paley, M.A.; Yang, M.; Carvidi, A.B.; Demissie, E.G.; El-Qunni, A.A.; Haile, A.; Huang, K.; Kinnett, B. Effect of Immunosuppression on the Immunogenicity of MRNA Vaccines to SARS-CoV-2: A Prospective Cohort Study. Ann. Intern. Med. 2021, 174, 1572–1585. [Google Scholar] [CrossRef] [PubMed]
  53. Stamatelopoulou, E.; Agriopoulou, S.; Dourtoglou, E.; Chatzilazarou, A.; Drosou, F.; Marinea, M.; Dourtoglou, V. Diketopiperazines in Wines. J. Wine Res. 2018, 29, 37–48. [Google Scholar] [CrossRef]
  54. Xing, J.; Yang, Z.; Lv, B.; Xiang, L. Rapid Screening for Cyclo-dopa and Diketopiperazine Alkaloids in Crude Extracts of Portulaca Oleracea L. Using Liquid Chromatography/Tandem Mass Spectrometry. Rapid Commun. Mass Spectrom. Int. J. Devoted Rapid Dissem. Up Minute Res. Mass Spectrom. 2008, 22, 1415–1422. [Google Scholar] [CrossRef]
  55. Pellegrino, R.M.; Blasi, F.; Angelini, P.; Ianni, F.; Alabed, H.B.R.; Emiliani, C.; Venanzoni, R.; Cossignani, L. LC/MS Q-TOF Metabolomic Investigation of Amino Acids and Dipeptides in Pleurotus Ostreatus Grown on Different Substrates. J. Agric. Food Chem. 2022, 70, 10371–10382. [Google Scholar] [CrossRef] [PubMed]
  56. Manganyi, M.C.; Ateba, C.N. Untapped Potentials of Endophytic Fungi: A Review of Novel Bioactive Compounds with Biological Applications. Microorganisms 2020, 8, 1934. [Google Scholar] [CrossRef] [PubMed]
  57. AK, A.U.; Demirkan, E.; Cengiz, M.; Sevgi, T.; Zeren, B.; Abdou, M. Optimization of Culture Medium for the Production and Partial Purification and Characterization of an Antibacterial Activity from Brevibacillus Laterosporus Strain EA62. Rom. Biotechnol. Lett. 2019, 24, 705–713. [Google Scholar] [CrossRef]
  58. Mohapatra, R.K.; Parhi, P.K.; Pandey, S.; Bindhani, B.K.; Thatoi, H.; Panda, C.R. Active and Passive Biosorption of Pb (II) Using Live and Dead Biomass of Marine Bacterium Bacillus Xiamenensis PbRPSD202: Kinetics and Isotherm Studies. J. Environ. Manag. 2019, 247, 121–134. [Google Scholar] [CrossRef]
  59. Oyedele, A.O.; Ogunbanwo, T.S. Antifungal Activities of Bacillus Subtilis Isolated from Some Condiments and Soil. Afr. J. Microbiol. Res. 2014, 8, 1841–1849. [Google Scholar] [CrossRef] [Green Version]
  60. Al-Ghazali, L.H.; Omran, R. Optimization of Medium Composition for Antibacterial Metabolite Production from Streptomyces sp. Asian J. Pharm. Clin. Res. 2017, 10, 381–385. [Google Scholar] [CrossRef] [Green Version]
  61. P de Carvalho, M.; Abraham, W.-R. Antimicrobial and Biofilm Inhibiting Diketopiperazines. Curr. Med. Chem. 2012, 19, 3564–3577. [Google Scholar] [CrossRef]
  62. Wang, X.; Li, Y.; Zhang, X.; Lai, D.; Zhou, L. Structural Diversity and Biological Activities of the Cyclodipeptides from Fungi. Molecules 2017, 22, 2026. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Espinosa-Salgado, R.; Tamayo-Galván, V.; Perraud-Gaime, I.; Rodríguez-Serrano, G.M.; González-Robles, R.O.; Durand, N.; Champion-Martínez, E.I.; Saucedo-Castañeda, G. Polyols Induce the Production of Antifungal Compounds by Lactobacillus Plantarum. Curr. Microbiol. 2022, 79, 99. [Google Scholar] [CrossRef] [PubMed]
  64. Qi, S.-H.; Xu, Y.; Gao, J.; Qian, P.-Y.; Zhang, S. Antibacterial and Antilarval Compounds from Marine BacteriumPseudomonas Rhizosphaerae. Ann. Microbiol. 2009, 59, 229–233. [Google Scholar] [CrossRef]
  65. Brauns, S.C.; Milne, P.; Naudé, R.; Van de Venter, M. Selected Cyclic Dipeptides Inhibit Cancer Cell Growth and Induce Apoptosis in HT-29 Colon Cancer Cells. Anticancer Res. 2004, 24, 1713–1719. [Google Scholar] [PubMed]
  66. Brauns, S.C.; Dealtry, G.; Milne, P.; Naudé, R.; Van de Venter, M. Caspase-3 Activation and Induction of PARP Cleavage by Cyclic Dipeptide Cyclo(Phe-Pro) in HT-29 Cells. Anticancer Res. 2005, 25, 4197–4202. [Google Scholar]
  67. Graz, M.; Hunt, A.; Jamie, H.; Grant, G.; Milne, P. Antimicrobial Activity of Selected Cyclic Dipeptides. Pharmazie 1999, 54, 772–775. [Google Scholar]
  68. Hentzer, M.; Givskov, M. Pharmacological Inhibition of Quorum Sensing for the Treatment of Chronic Bacterial Infections. J. Clin. Investig. 2003, 112, 1300–1307. [Google Scholar] [CrossRef] [Green Version]
  69. Ström, K.; Sjögren, J.; Broberg, A.; Schnürer, J. Lactobacillus Plantarum MiLAB 393 Produces the Antifungal Cyclic Dipeptides Cyclo (l-Phe-l-Pro) and Cyclo (l-Phe-Trans-4-OH-l-Pro) and 3-Phenyllactic Acid. Appl. Environ. Microbiol. 2002, 68, 4322–4327. [Google Scholar] [CrossRef] [Green Version]
  70. Balaure, P.C.; Grumezescu, A.M. Recent Advances in Surface Nanoengineering for Biofilm Prevention and Control. Part II: Active, Combined Active and Passive, and Smart Bacteria-Responsive Antibiofilm Nanocoatings. Nanomaterials 2020, 10, 1527. [Google Scholar] [CrossRef]
  71. Desjardine, K.; Pereira, A.; Wright, H.; Matainaho, T.; Kelly, M.; Andersen, R.J. Tauramamide, a Lipopeptide Antibiotic Produced in Culture by Brevibacillus Laterosporus Isolated from a Marine Habitat: Structure Elucidation and Synthesis. J. Nat. Prod. 2007, 70, 1850–1853. [Google Scholar] [CrossRef]
  72. Liu, Z.; Jiao, D. Necroptosis, Tumor Necrosis and Tumorigenesis. Cell Stress 2019, 4, 1–8. [Google Scholar] [CrossRef] [PubMed]
  73. Kumar, S.N.; Mohandas, C.; Nambisan, B.; Sreerag, R.S.; Jayaprakas, C.A. Cyclo(l-Pro-d-Arg): A New Antibacterial and Antitumour Diketopiperazine from Bacillus Cereus Associated with a Rhabditid Entomopathogenic. Folia Microbiol. 2014, 59, 197–202. [Google Scholar] [CrossRef] [PubMed]
Figure 1. A maximum likelihood phylogenetic tree constructed based on the 16S rDNA sequences (V1–9) from various bacterial strains. The homologous sequence from Lysinibacillus fusiformis N43 was used to root the tree.
Figure 1. A maximum likelihood phylogenetic tree constructed based on the 16S rDNA sequences (V1–9) from various bacterial strains. The homologous sequence from Lysinibacillus fusiformis N43 was used to root the tree.
Metabolites 12 01102 g001
Figure 2. An agarose gel (1.5%) of the gradient PCR, where the annealing temperatures were lane 1, 68 °C; lane 2, 66.5 °C; lane 3, 63.9 °C; lane 4, 60 °C; lane 5, 55.5 °C; lane 6, 51.8 °C; lane 7, 49.4 °C; and lane 8, 48 °C. Marker (M), Thermo Scientific GeneRuler DNA ladder Mix (#SM0331).
Figure 2. An agarose gel (1.5%) of the gradient PCR, where the annealing temperatures were lane 1, 68 °C; lane 2, 66.5 °C; lane 3, 63.9 °C; lane 4, 60 °C; lane 5, 55.5 °C; lane 6, 51.8 °C; lane 7, 49.4 °C; and lane 8, 48 °C. Marker (M), Thermo Scientific GeneRuler DNA ladder Mix (#SM0331).
Metabolites 12 01102 g002
Figure 3. A maximum likelihood phylogenetic tree constructed based on the DNA gyrase subunit B (gyrB) gene sequences from various bacterial strains.
Figure 3. A maximum likelihood phylogenetic tree constructed based on the DNA gyrase subunit B (gyrB) gene sequences from various bacterial strains.
Metabolites 12 01102 g003
Figure 4. Effect of different growth conditions on the antibacterial activity of B. laterosporus bioactive extract; (A) different growth media, (B) different incubation periods, (C) different temperatures in the GPM, (D) different pH levels and (E) different carbon sources, (F) different nitrogen sources. The significance among different conditions was measured by Tukey’s honest significant difference (Tukey’s HSD, p < 0.05) using Agricolae package in R language [50,51]. Identical letters indicate that the difference is not statistically significant.
Figure 4. Effect of different growth conditions on the antibacterial activity of B. laterosporus bioactive extract; (A) different growth media, (B) different incubation periods, (C) different temperatures in the GPM, (D) different pH levels and (E) different carbon sources, (F) different nitrogen sources. The significance among different conditions was measured by Tukey’s honest significant difference (Tukey’s HSD, p < 0.05) using Agricolae package in R language [50,51]. Identical letters indicate that the difference is not statistically significant.
Metabolites 12 01102 g004
Figure 5. Molecular network of 165 metabolites of B. laterosporus MeOH extract and the blank. The gray nodes refer to the blank. The green nodes refer to the metabolites from the B. laterosporus MeOH extract. Blue nodes refer to the similar metabolites between the extract and blank. All the metabolites identified by name took a triangle shape.
Figure 5. Molecular network of 165 metabolites of B. laterosporus MeOH extract and the blank. The gray nodes refer to the blank. The green nodes refer to the metabolites from the B. laterosporus MeOH extract. Blue nodes refer to the similar metabolites between the extract and blank. All the metabolites identified by name took a triangle shape.
Metabolites 12 01102 g005
Figure 6. Schematic figure prescribing a base peak chromatogram of B. laterosporus and fragmentation of Cyclo (Ile-Tyr) (4), Tyr-Pro (6), and cholic acid (7).
Figure 6. Schematic figure prescribing a base peak chromatogram of B. laterosporus and fragmentation of Cyclo (Ile-Tyr) (4), Tyr-Pro (6), and cholic acid (7).
Metabolites 12 01102 g006
Figure 7. Schematic figure of MS2 spectrum of B. laterosporus and fragmentation of Cyclo (Leu-Pro) (1), Cyclo-(Val-Phe) (2), Cyclo (Tyr-Pro) (3), and Cyclo (Phe-Pro) (5).
Figure 7. Schematic figure of MS2 spectrum of B. laterosporus and fragmentation of Cyclo (Leu-Pro) (1), Cyclo-(Val-Phe) (2), Cyclo (Tyr-Pro) (3), and Cyclo (Phe-Pro) (5).
Metabolites 12 01102 g007
Figure 8. The viability of control and extract-exposed MCF-7 and Vero cell lines were tested using the MTT assay. The incubation with serial concentrations (log concentration 0–1000 µg/mL) was performed in triplicate. Data are illustrated as (mean ± SD) of three separate experiments.
Figure 8. The viability of control and extract-exposed MCF-7 and Vero cell lines were tested using the MTT assay. The incubation with serial concentrations (log concentration 0–1000 µg/mL) was performed in triplicate. Data are illustrated as (mean ± SD) of three separate experiments.
Metabolites 12 01102 g008
Figure 9. The antitumor effect of B. laterosporus bioactive extract (4 and 8 µg/mL) on MCF 7 after 72 h of the treatments. The flow cytometric quantification of apoptosis was performed using Annexin V-FITC/PI assay and PI staining. (A) Flow cytometric dot plot presentation shows the percentages of apoptotic and necrotic events. (B) The statistical data of treated and control groups of apoptosis/necrosis. All values are presented as mean ± SD (n = 3). Significant differences (p < 0.05) between groups are shown by different letters.
Figure 9. The antitumor effect of B. laterosporus bioactive extract (4 and 8 µg/mL) on MCF 7 after 72 h of the treatments. The flow cytometric quantification of apoptosis was performed using Annexin V-FITC/PI assay and PI staining. (A) Flow cytometric dot plot presentation shows the percentages of apoptotic and necrotic events. (B) The statistical data of treated and control groups of apoptosis/necrosis. All values are presented as mean ± SD (n = 3). Significant differences (p < 0.05) between groups are shown by different letters.
Metabolites 12 01102 g009
Figure 10. The anticancer effect of B. laterosporus BF202 (4 and 8 µg/mL) on MCF 7 after 72 h of the treatments. The flow cytometric quantification of the cell cycle distribution was performed using PI staining. (A) Flow cytometric histograms show the distribution of the cell cycle phases. (B) The statistical data of treated and control groups of cell cycle phases. All values are presented as mean ± SD (n = 3). Significant differences (p < 0.05) between groups at the same phase are shown by different letters.
Figure 10. The anticancer effect of B. laterosporus BF202 (4 and 8 µg/mL) on MCF 7 after 72 h of the treatments. The flow cytometric quantification of the cell cycle distribution was performed using PI staining. (A) Flow cytometric histograms show the distribution of the cell cycle phases. (B) The statistical data of treated and control groups of cell cycle phases. All values are presented as mean ± SD (n = 3). Significant differences (p < 0.05) between groups at the same phase are shown by different letters.
Metabolites 12 01102 g010
Table 1. Antibacterial activities of the isolated strains against the pathogenic bacteria using the paper disc method.
Table 1. Antibacterial activities of the isolated strains against the pathogenic bacteria using the paper disc method.
Microbial IsolatesInhibition Zone Diameters
E. coliS. typhiS. aureusK. pneumoniae
19 ± 2.64 c11 ± 4.58 bc7 ± 1.73 d10 ± 3.46 bc
2-16 ± 2.64 ab12 ± 3.00 bcd17 ± 2.00 ab
3-7 ± 1.00 cd-9 ± 1.73 c
411 ± 1.00 bc15 ± 2.64 abc-12 ± 2.00 abc
521 ± 2.64 a20 ± 7.00 a20 ± 4.35 a19 ± 2.64 a
615 ± 2.64 abc11 ± 2.64 bc--
7---12 ± 2.64 abc
89 ± 1.00 c12 ± 1.73 abc--
9--11 ± 1.30 cd14 ± 3.30 abc
10----
1111 ± 1.73 bc13 ± 3.00 abc10 ± 1.00 cd9 ± 1.73 c
12--14 ± 4.35 abc12 ± 1.00 abc
1310 ± 4.35 bc--12 ± 3.46 abc
14-14 ± 2.00 abc10 ± 2.64 cd11 ± 2.64 bc
1515 ± 4.35 abc13 ± 4.35 abc--
1616 ± 4.35 ab13 ± 3.60 abc15 ± 2.64 abc16 ± 4.35 abc
17--15 ± 2.64 abc10 ± 1.00 bc
1811 ± 1.73 bc15 ± 2.64 abc--
19--18 ± 4.35 ab12 ± 3.46 abc
2019 ± 1.00 a17 ± 2.64 ab-14 ± 2.64 abc
All values are presented as mean ± SD, (n = 3). The significance among growth inhibition zone diameters of each microbial isolate’s filtrate of the four selected pathogens was measured by Tukey’s HSD. Different letters represent significance, p < 0.05.
Table 2. Activity of cell culture supernatant of B. laterosporus BF202.
Table 2. Activity of cell culture supernatant of B. laterosporus BF202.
PathogensInhibition Zone Diameters (mm)
Bacterial FiltrateLevofloxacin
E. coli23 ± 1.00 b33 ± 2.64 a
S. typhi22 ± 2.64 b34 ± 3.60 a
S. aureus20 ± 2.64 b31 ± 2.64 a
K. pneumoniae19 ± 2.64 b32 ± 1.00 a
All values are presented as mean ± SD, (n = 3) and the significance among growth inhibition zone diameters was measured by Tukey’s HSD. Different letters represent significance, p < 0.05.
Table 3. List of the identified metabolites, parent masses, and their fragments from the raw mass spectrum compared with that of the molecular networking database.
Table 3. List of the identified metabolites, parent masses, and their fragments from the raw mass spectrum compared with that of the molecular networking database.
Compound NameParent Mass
m/z (g/mol)
AdductRaw Material FragmentsLiterature FragmentStructureSource
Cyclo (Leu-Pro)
1
211.257[M + H]+183.37, 155.17, 138.19, 86.14 and 70.11154.1, 138.1, 125.1, 110.1, 98.1, 84.1, and 70.1 [53]Metabolites 12 01102 i001Brevibacillus laterosporus-
Bacillus sp.
Cyclo-(Val-Phe)
2
245.24[M-H]219.16, 202.13 and 120.08219, 202, 174, 157, and 120 [54]Metabolites 12 01102 i002Endophytic Streptomyces
Cyclo (Tyr-Pro)
3
261.188[M + H] +233.13, 155.08, 147.04 and 136.08NAMetabolites 12 01102 i003Bacillus sp.
Cyclo (Ile-Tyr)
4
277.29[M + H] +249.16, 232.13, 171.11 and 136.08249, 232, 204,171, and 136 [54]Metabolites 12 01102 i004Marine-Derived Bacteria Harizani
Cyclo (Phe-Pro)
5
245.131[M + H] +120.09 and 70.07217, 200, 172, 154, 120, and 70 [54]Metabolites 12 01102 i005Endophytic Streptomyces
Tyr-Pro
6
279.255[M + H] +136.08 and 116.07147.04, 142.95, 137.07, 136.07, 121.05, 119.04, 118.06, 116.06, 109.06, 92.05, 71.06, and 70.06 [55]Metabolites 12 01102 i006Marine-Derived Bacteria
Cholic acid
7
374.454[M + H-2H2O] +355.21 and 337.19N/AMetabolites 12 01102 i007Fecal Bacteria from Cholesterol Gallstone Patients
Marine Ascidian-Associated Bacterium Hasllibacter halocynthiae
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zayed, M.; El-Garawani, I.M.; El-Sabbagh, S.M.; Amr, B.; Alsharif, S.M.; Tayel, A.A.; AlAjmi, M.F.; Ibrahim, H.M.S.; Shou, Q.; Khalifa, S.A.M.; et al. Structural Diversity, LC-MS-MS Analysis and Potential Biological Activities of Brevibacillus laterosporus Extract. Metabolites 2022, 12, 1102. https://doi.org/10.3390/metabo12111102

AMA Style

Zayed M, El-Garawani IM, El-Sabbagh SM, Amr B, Alsharif SM, Tayel AA, AlAjmi MF, Ibrahim HMS, Shou Q, Khalifa SAM, et al. Structural Diversity, LC-MS-MS Analysis and Potential Biological Activities of Brevibacillus laterosporus Extract. Metabolites. 2022; 12(11):1102. https://doi.org/10.3390/metabo12111102

Chicago/Turabian Style

Zayed, Muhammad, Islam M. El-Garawani, Sabha M. El-Sabbagh, Bassem Amr, Sultan M. Alsharif, Ahmed A. Tayel, Mohamed F. AlAjmi, Hasnaa M. S. Ibrahim, Qiyang Shou, Shaden A. M. Khalifa, and et al. 2022. "Structural Diversity, LC-MS-MS Analysis and Potential Biological Activities of Brevibacillus laterosporus Extract" Metabolites 12, no. 11: 1102. https://doi.org/10.3390/metabo12111102

APA Style

Zayed, M., El-Garawani, I. M., El-Sabbagh, S. M., Amr, B., Alsharif, S. M., Tayel, A. A., AlAjmi, M. F., Ibrahim, H. M. S., Shou, Q., Khalifa, S. A. M., El-Seedi, H. R., & Elfeky, N. (2022). Structural Diversity, LC-MS-MS Analysis and Potential Biological Activities of Brevibacillus laterosporus Extract. Metabolites, 12(11), 1102. https://doi.org/10.3390/metabo12111102

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop